- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
SonoSite handheld system will go into battle
The 19 member countries of NATO will purchase the SonoSite 180 handheld ultrasound system for diagnostic and imaging use on the battlefield. SonoSite received Food and Drug Administration clearance for the 5-pound digital handheld ultrasound early last
The 19 member countries of NATO will purchase the SonoSite 180 handheld ultrasound system for diagnostic and imaging use on the battlefield.
SonoSite received Food and Drug Administration clearance for the 5-pound digital handheld ultrasound early last year. The British Armed Forces use the SonoSite 180, which can scan any area of the body for bullets or evidence of trauma.
NATO will purchase the devices for about $20,000 each, depending on how many scanheads are included in the unit, said Kelly Ford, director of marketing communications. Four years ago, Bothell, WA-based SonoSite entered into a contract with the U.S. Department of Defense Advanced Research Project Agency to develop an ultrasound device for use on the battlefield. Studies are under way to explore the best use of this equipment to improve diagnosis and treatment in military trauma situations.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
